UCR Startup Receives $2.25 Million to Test New Cancer Drug
Riverside company's treatment targets aggressive tumors including pancreatic cancer.
A roundup of recent legal stories affecting Riversiders from our friends at Follow Our Courts.
Here鈥檚 a roundup of recent legal stories affecting Riversiders from our friends at Follow Our Courts, who cover legal news in the Inland Empire:
Follow Our Courts reports on cases, legislation, and courthouse happenings in the Inland Empire at followourcourts.com.
Let us email you Riverside's news and events every morning. For free!